Document Detail

Anti-vascular endothelial growth factor antibody single therapy for pancreatic neuroendocrine carcinoma exhibits a marked tumor growth-inhibitory effect.
MedLine Citation:
PMID:  22977618     Owner:  NLM     Status:  Publisher    
At present, no effective chemotherapy for pancreatic neuroendocrine carcinoma (PNEC) exists. However, anti-angiogenic therapy is expected to be effective for PNEC, a hypervascular tumor. We treated PNEC and hypovascular pancreatic ductal cell carcinoma (DCC) cell lines with the anti-vascular endothelial growth factor (VEGF) antibody bevacizumab, and compared the antitumor effect between the two different types of cell lines. The PNEC cell line QGP-1 and the DCC cell lines BxPC-3 and AsPC-1 were used. We evaluated the ability of the cell lines to proliferate and secrete VEGF in vitro, the antitumor effect of bevacizumab administration in vivo and the side effects of bevacizumab on the pancreas in a caerulein-induced pancreatitis model. Comparison of the QGP-1 and DCC cell lines showed that QGP-1 secreted a higher level of VEGF under a hypoxic environment than the DCC cell line, and bevacizumab exerted the most marked growth-inhibitory effect on QGP-1; the number of intratumoral blood vessels decreased and the percentage of proliferating cells was approximately the same. In the pancreatitis model, bevacizumab administration did not adversely affect the pancreatitis or the associated hypoxic environment. Bevacizumab does not affect the pancreas itself; therefore, its potent inhibitory effect on the growth of pancreatic neuroendocrine tumors alone can be expected.
Kazuhiko Kasuya; Yuichi Nagakawa; Minako Suzuki; Hiroaki Tanaka; Hiroshi Ohta; Takao Itoi; Akihiko Tsuchida
Related Documents :
19002828 - Metabolism of amyloid precursor protein in cos cells transfected with a beta-secretase ...
17327438 - No evidence for mouse pancreatic beta-cell epithelial-mesenchymal transition in vitro.
6500998 - Isolation, culture, and preliminary characterization of ellipsoids (sheathed capillarie...
9699008 - Mechanisms of resistance to oxidative stress in alzheimer's disease.
11787628 - Regulation of high affinity taurine transport in goldfish and rat retinal cells.
20148898 - The presence of professional phagocytes dictates the number of host cells targeted for ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-9-5
Journal Detail:
Title:  Experimental and therapeutic medicine     Volume:  2     ISSN:  1792-1015     ISO Abbreviation:  Exp Ther Med     Publication Date:  2011 11 
Date Detail:
Created Date:  2012-9-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101531947     Medline TA:  Exp Ther Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1047-1052     Citation Subset:  -    
Department of Digestive Surgery, Tokyo Medical University;
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Expression profiling and identification of potential molecular targets for therapy in pulmonary larg...
Next Document:  Decreased expression of LMO7 and its clinicopathological significance in human lung adenocarcinoma.